11.9 C
Madrid
Sunday, May 9, 2021

Malawi Acquires Oxford-AstraZeneca COVID-19 Vaccine

Chakwera has announced that Malawi's scientists at the Malawi Liverpool Welcome Trust Lab at Queen Elizabeth Central hospital now have the capacity to sequence the virus that causes COVID-19

Must read

Godfrey Maotcha
Godfrey Maotcha
Born and grew up in Blantyre Malawi. Worked for the Guardian ( local newspaper) and Montfort Media for six years. A print and online media house. Currently lives in Lilongwe Malawi

MALAWI. Lilongwe: Malawi’s president Lazarus Chakwera has said that Malawi has secured doses of the Oxford-AstraZeneca vaccine in an effort to curb the COVID-19 virus. While addressing the nation on Sunday, Chakwera said that the first consignment of the vaccine will arrive in the country at the end of February.

According to the reports, around 90 percent of the country’s population is expected to receive the doses. However, the first priority will be given to the frontline workers, the elderly, and those with underlying health conditions.

“Our own scientists in our own laboratories will verify the safety of the vaccine, and will give full information so that no one is misled by social media lies against vaccination that scientists have worked so hard to save lives”, Chakwera assured.

- Advertisement -

Chakwera has announced that Malawi’s scientists at the Malawi Liverpool Welcome Trust Lab at Queen Elizabeth Central hospital now have the capacity to sequence the virus that causes COVID-19.

He added that Malawi has partnered with the African and US Centers for Disease Control to bring the same capacity to the National Public Health Lab in Lilongwe.

- Advertisement -

Read Also: Oxford-AstraZeneca COVID-19 Vaccine Approved In UK

Around 77 new COVID-19 tests have been established in the past two weeks. “We have also stocked our warehouse with 150,000 testing kits, which will last us the whole month of February while a new consignment is on the way,” Chakwera said.

- Advertisement -

The British manufactured Oxford-AstraZeneca vaccine costs $4 per dose and is believed to be up to 90 percent effective in protecting against COVID-19.

Support our mission of Independent Journalism on Patreon!
- Advertisement -

More articles

1 COMMENT


  1. Notice: Trying to get property 'ID' of non-object in /home/tctimes/public_html/wp-content/plugins/molongui-authorship/includes/class-post.php on line 572

    Notice: Trying to get property 'ID' of non-object in /home/tctimes/public_html/wp-content/plugins/molongui-authorship/includes/class-post.php on line 572

    Notice: Trying to get property 'ID' of non-object in /home/tctimes/public_html/wp-content/plugins/molongui-authorship/includes/class-post.php on line 572

    Notice: Trying to get property 'ID' of non-object in /home/tctimes/public_html/wp-content/plugins/molongui-authorship/includes/class-post.php on line 572
    Malawi Starts COVID-19 Vaccination Campaign | Transcontinental Times

    […] Read Also: Malawi Acquires Oxford-AstraZeneca COVID-19 Vaccine […]

- Advertisement -

Latest article

Support our mission of Independent Journalism on Patreon!